HRP20190050T1 - Farmaceutski pripravci za kombinacijsku terapiju - Google Patents
Farmaceutski pripravci za kombinacijsku terapijuInfo
- Publication number
- HRP20190050T1 HRP20190050T1 HRP20190050TT HRP20190050T HRP20190050T1 HR P20190050 T1 HRP20190050 T1 HR P20190050T1 HR P20190050T T HRP20190050T T HR P20190050TT HR P20190050 T HRP20190050 T HR P20190050T HR P20190050 T1 HRP20190050 T1 HR P20190050T1
- Authority
- HR
- Croatia
- Prior art keywords
- combination therapy
- pharmaceutical preparations
- preparations
- pharmaceutical
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261599623P | 2012-02-16 | 2012-02-16 | |
| DKPA201270076 | 2012-02-16 | ||
| PCT/EP2013/052941 WO2013120935A1 (en) | 2012-02-16 | 2013-02-14 | Pharmaceutical compositions for combination therapy |
| EP13703834.5A EP2814473B1 (en) | 2012-02-16 | 2013-02-14 | Pharmaceutical compositions for combination therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190050T1 true HRP20190050T1 (hr) | 2019-03-08 |
Family
ID=48983571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190050TT HRP20190050T1 (hr) | 2012-02-16 | 2013-02-14 | Farmaceutski pripravci za kombinacijsku terapiju |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9211271B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2814473B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6203760B2 (cg-RX-API-DMAC7.html) |
| CN (3) | CN108853071A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013220424B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2864264C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2814473T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA029543B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2704987T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20190050T1 (cg-RX-API-DMAC7.html) |
| LT (1) | LT2814473T (cg-RX-API-DMAC7.html) |
| PL (1) | PL2814473T3 (cg-RX-API-DMAC7.html) |
| SI (1) | SI2814473T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013120935A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108853071A (zh) * | 2012-02-16 | 2018-11-23 | 萨尼奥纳有限责任公司 | 用于联合治疗的药物组合物 |
| CN105940759B (zh) * | 2013-12-28 | 2021-01-22 | 英特尔公司 | 基于用户上下文检测的装置动作和配置的系统和方法 |
| MA41634B1 (fr) | 2015-03-03 | 2021-09-30 | Saniona As | Formulation à base de combinaison de tésofensine et de métoprolol |
| US20190060301A1 (en) | 2016-01-15 | 2019-02-28 | Saniona A/S | Tesofensine and metoprolol for treatment of hypertension |
| EP3509597A1 (en) | 2016-09-07 | 2019-07-17 | Saniona A/S | Tesofensine compositions |
| WO2020144146A1 (en) | 2019-01-07 | 2020-07-16 | Saniona A/S | Tesofensine for reduction of body weight in prader-willi patients |
| CN110297826B (zh) * | 2019-05-31 | 2020-12-11 | 南京理工大学 | 基于json动态解析卫星遥测数据的方法 |
| JP7784144B2 (ja) | 2020-04-22 | 2025-12-11 | サニオナ エー／エス | 視床下部性肥満症の処置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992016197A1 (en) * | 1991-03-18 | 1992-10-01 | Sepracor Inc. | Composition and method containing optically pure (s) metoprolol |
| RU2167876C2 (ru) | 1996-02-22 | 2001-05-27 | Ньюросерч А/С | 2,3-трансдизамещенное тропановое производное, способ его получения, фармацевтическая композиция |
| EP1727547A1 (en) | 2004-01-22 | 2006-12-06 | Neurosearch A/S | Compounds for the sustained reduction of body weight |
| US20110118304A1 (en) | 2007-11-20 | 2011-05-19 | Neurosearch A/S | Method for treating over-eating disorders |
| EP2237781A2 (en) | 2007-12-20 | 2010-10-13 | NeuroSearch A/S | Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity |
| WO2009080693A2 (en) * | 2007-12-20 | 2009-07-02 | Neurosearch A/S | Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker |
| WO2011100659A2 (en) * | 2010-02-12 | 2011-08-18 | Kitov Pharmaceutical Ltd. | Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs |
| CN108853071A (zh) * | 2012-02-16 | 2018-11-23 | 萨尼奥纳有限责任公司 | 用于联合治疗的药物组合物 |
| MA41634B1 (fr) * | 2015-03-03 | 2021-09-30 | Saniona As | Formulation à base de combinaison de tésofensine et de métoprolol |
-
2013
- 2013-02-14 CN CN201810580312.2A patent/CN108853071A/zh active Pending
- 2013-02-14 JP JP2014557034A patent/JP6203760B2/ja active Active
- 2013-02-14 EP EP13703834.5A patent/EP2814473B1/en active Active
- 2013-02-14 EA EA201491532A patent/EA029543B1/ru not_active IP Right Cessation
- 2013-02-14 AU AU2013220424A patent/AU2013220424B2/en not_active Ceased
- 2013-02-14 WO PCT/EP2013/052941 patent/WO2013120935A1/en not_active Ceased
- 2013-02-14 SI SI201331313T patent/SI2814473T1/sl unknown
- 2013-02-14 LT LTEP13703834.5T patent/LT2814473T/lt unknown
- 2013-02-14 PL PL13703834T patent/PL2814473T3/pl unknown
- 2013-02-14 CN CN201380020405.5A patent/CN104244935A/zh active Pending
- 2013-02-14 CA CA2864264A patent/CA2864264C/en active Active
- 2013-02-14 HR HRP20190050TT patent/HRP20190050T1/hr unknown
- 2013-02-14 ES ES13703834T patent/ES2704987T3/es active Active
- 2013-02-14 US US14/379,032 patent/US9211271B2/en active Active
- 2013-02-14 DK DK13703834.5T patent/DK2814473T3/en active
- 2013-02-14 CN CN201810575583.9A patent/CN108434129A/zh active Pending
-
2015
- 2015-11-10 US US14/936,963 patent/US9387184B2/en active Active
-
2016
- 2016-07-11 US US15/206,477 patent/US20170007557A1/en not_active Abandoned
-
2018
- 2018-02-27 US US15/906,350 patent/US20180185304A1/en not_active Abandoned
-
2021
- 2021-07-27 US US17/386,098 patent/US20220016055A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN108434129A (zh) | 2018-08-24 |
| US9211271B2 (en) | 2015-12-15 |
| AU2013220424B2 (en) | 2017-03-23 |
| EP2814473A1 (en) | 2014-12-24 |
| US20180185304A1 (en) | 2018-07-05 |
| ES2704987T3 (es) | 2019-03-21 |
| US20160074344A1 (en) | 2016-03-17 |
| EA201491532A1 (ru) | 2015-01-30 |
| DK2814473T3 (en) | 2019-01-28 |
| LT2814473T (lt) | 2019-01-25 |
| HK1204946A1 (en) | 2015-12-11 |
| PL2814473T3 (pl) | 2019-06-28 |
| US20220016055A1 (en) | 2022-01-20 |
| US20170007557A1 (en) | 2017-01-12 |
| CN108853071A (zh) | 2018-11-23 |
| CA2864264C (en) | 2020-05-05 |
| JP6203760B2 (ja) | 2017-09-27 |
| US9387184B2 (en) | 2016-07-12 |
| SI2814473T1 (sl) | 2019-03-29 |
| EA029543B1 (ru) | 2018-04-30 |
| JP2015508765A (ja) | 2015-03-23 |
| AU2013220424A1 (en) | 2014-09-25 |
| US20150025107A1 (en) | 2015-01-22 |
| CA2864264A1 (en) | 2013-08-22 |
| EP2814473B1 (en) | 2018-10-10 |
| WO2013120935A1 (en) | 2013-08-22 |
| CN104244935A (zh) | 2014-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289300A (en) | Combination therapy for treating cancer | |
| IL275998B (en) | Medical system | |
| HUE056014T2 (hu) | Lipidek gyógyszerszállító készítményekhez | |
| HRP20182069T1 (hr) | Farmaceutski pripravci za liječenje alzheimerove bolesti | |
| EP2922877A4 (en) | IMPROVED PEPTIDATE MEDICINES | |
| DK3067358T3 (da) | Polycykliske carbamoylpyridon-forbindelser og deres farmaceutiske anvendelse | |
| IL230838A0 (en) | Pharmaceutical compositions | |
| HRP20180939T1 (hr) | Kombinirana terapija za liječenje multiple skleroze | |
| HUE045314T2 (hu) | Kombinációs terápia rák kezelésére | |
| EP2804606A4 (en) | TOPICAL THERAPEUTIC FORMULATIONS | |
| CO6940426A2 (es) | Formulaciones farmacéuticas | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| HRP20190050T1 (hr) | Farmaceutski pripravci za kombinacijsku terapiju | |
| CL2014003283A1 (es) | Formulación farmacéutica. | |
| HUE053273T2 (hu) | Opioid készítmények | |
| BR112014015885A8 (pt) | preparação farmacêutica | |
| HRP20182041T1 (hr) | Pripravci oksprenolola za liječenje raka | |
| AP2015008208A0 (en) | Pharmaceutical administration forms comprising | |
| EP2883547A4 (en) | MEDICINE | |
| EP2832355A4 (en) | CANCER AGENT | |
| DK2735305T3 (da) | Stabiliserede flydende farmaceutiske præparater | |
| DK2854765T3 (da) | Farmaceutisk pemetrexed-opløsning | |
| HRP20181707T1 (hr) | Sustav za isporuku lijeka | |
| GB201318686D0 (en) | Pharmaceutical preparations | |
| CO7091176A2 (es) | Diagnóstico farmacéutico |